• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Molecular basis of heterogeneity in small cell lung cancer.

作者信息

Tenjin Yuki

机构信息

Department of Respiratory Medicine, Kumamoto University, Graduate School of Medical Science Kumamoto University, Graduate School of Medical Sciences, Chuo-ku, Kumamoto, Japan.

Department of Respiratory Medicine, Miyazaki Prefectural Nobeoka Hospital, Nobeoka, Miyazaki, Japan.

出版信息

Transl Cancer Res. 2022 Dec;11(12):4237-4240. doi: 10.21037/tcr-22-2224.

DOI:10.21037/tcr-22-2224
PMID:36644189
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9834598/
Abstract
摘要
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b2a1/9834598/c94b6f2817d8/tcr-11-12-4237-f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b2a1/9834598/c94b6f2817d8/tcr-11-12-4237-f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b2a1/9834598/c94b6f2817d8/tcr-11-12-4237-f1.jpg

相似文献

1
Molecular basis of heterogeneity in small cell lung cancer.小细胞肺癌异质性的分子基础。
Transl Cancer Res. 2022 Dec;11(12):4237-4240. doi: 10.21037/tcr-22-2224.
2
The role of molecular heterogeneity targeting resistance mechanisms to lung cancer therapies.靶向肺癌治疗耐药机制的分子异质性的作用。
Expert Rev Mol Diagn. 2021 Aug;21(8):757-766. doi: 10.1080/14737159.2021.1943365. Epub 2021 Jul 18.
3
Molecular profiling of human non-small cell lung cancer by single-cell RNA-seq.单细胞 RNA 测序对人类非小细胞肺癌的分子谱分析。
Genome Med. 2022 Aug 13;14(1):87. doi: 10.1186/s13073-022-01089-9.
4
Inter-heterogeneity and intra-heterogeneity of αβ in non-small cell lung cancer and small cell lung cancer patients as revealed by Ga-RGD PET imaging.Ga-RGD PET 成像揭示的非小细胞肺癌和小细胞肺癌患者中αβ 的异质性。
Eur J Nucl Med Mol Imaging. 2017 Aug;44(9):1520-1528. doi: 10.1007/s00259-017-3696-2. Epub 2017 Apr 12.
5
Lung cancer histologic and immunohistochemical heterogeneity in the era of molecular therapies: analysis of 172 consecutive surgically resected, entirely sampled pulmonary carcinomas.在分子治疗时代的肺癌组织学和免疫组织化学异质性：对 172 例连续手术切除、完全采样的肺癌的分析。
Am J Surg Pathol. 2014 Apr;38(4):502-9. doi: 10.1097/PAS.0000000000000154.
6
Heterogeneity in Lung Cancer.肺癌的异质性。
Pathobiology. 2018;85(1-2):96-107. doi: 10.1159/000487440. Epub 2018 Apr 10.
7
Mutation patterns in small cell and non-small cell lung cancer patients suggest a different level of heterogeneity between primary and metastatic tumors.小细胞肺癌和非小细胞肺癌患者的突变模式表明，原发性肿瘤和转移性肿瘤之间的异质性水平不同。
Carcinogenesis. 2017 Feb 1;38(2):144-151. doi: 10.1093/carcin/bgw128.
8
Clinically validated model predicts the effect of intratumoral heterogeneity on overall survival for non-small cell lung cancer (NSCLC) patients.临床验证模型预测了肿瘤内异质性对非小细胞肺癌（NSCLC）患者总生存期的影响。
Comput Methods Programs Biomed. 2021 Nov;212:106455. doi: 10.1016/j.cmpb.2021.106455. Epub 2021 Oct 12.
9
Multiregion sequencing reveals the intratumor heterogeneity of driver mutations in TP53-driven non-small cell lung cancer.多区域测序揭示了TP53驱动的非小细胞肺癌中驱动基因突变的肿瘤内异质性。
Int J Cancer. 2017 Jan 1;140(1):103-108. doi: 10.1002/ijc.30437. Epub 2016 Oct 3.
10
Correlation between mucin biology and tumor heterogeneity in lung cancer.肺癌中黏蛋白生物学与肿瘤异质性的相关性。
Semin Cell Dev Biol. 2017 Apr;64:73-78. doi: 10.1016/j.semcdb.2016.08.027. Epub 2016 Aug 26.

引用本文的文献

1
Polysaccharides of Atractylodes macrocephala Koidz alleviate bursa of Fabricius involution in Magang geese by inhibiting the Wnt signaling pathway.白术多糖通过抑制Wnt信号通路减轻马岗鹅法氏囊退化
Poult Sci. 2025 Jul;104(7):105227. doi: 10.1016/j.psj.2025.105227. Epub 2025 May 1.

本文引用的文献

1
A case report of pulmonary combined small cell carcinoma with enteric adenocarcinoma.肺小细胞癌合并肠腺癌一例报告
Transl Cancer Res. 2022 Oct;11(10):3890-3894. doi: 10.21037/tcr-22-1171.
2
Cell plasticity in patients with NSCLC: The controversial origins of transformed SCLC.非小细胞肺癌患者的细胞可塑性：转化型小细胞肺癌的争议起源。
Biomed Pharmacother. 2022 May;149:112909. doi: 10.1016/j.biopha.2022.112909. Epub 2022 Apr 5.
3
The role of YAP1 in small cell lung cancer.YAP1 在小细胞肺癌中的作用。
Hum Cell. 2022 Mar;35(2):628-638. doi: 10.1007/s13577-022-00669-6. Epub 2022 Jan 24.
4
Distinct transcriptional programs of SOX2 in different types of small cell lung cancers.不同类型小细胞肺癌中 SOX2 的不同转录程序。
Lab Invest. 2020 Dec;100(12):1575-1588. doi: 10.1038/s41374-020-00479-0. Epub 2020 Aug 14.
5
Durvalumab plus platinum-etoposide versus platinum-etoposide in first-line treatment of extensive-stage small-cell lung cancer (CASPIAN): a randomised, controlled, open-label, phase 3 trial.度伐利尤单抗联合铂类依托泊苷与铂类依托泊苷一线治疗广泛期小细胞肺癌（CASPIAN）：一项随机、对照、开放标签、III 期临床试验。
Lancet. 2019 Nov 23;394(10212):1929-1939. doi: 10.1016/S0140-6736(19)32222-6. Epub 2019 Oct 4.
6
Ascl1-induced Wnt11 regulates neuroendocrine differentiation, cell proliferation, and E-cadherin expression in small-cell lung cancer and Wnt11 regulates small-cell lung cancer biology.Ascl1 诱导的 Wnt11 调节小细胞肺癌的神经内分泌分化、细胞增殖和 E-钙黏蛋白表达，Wnt11 调节小细胞肺癌生物学。
Lab Invest. 2019 Nov;99(11):1622-1635. doi: 10.1038/s41374-019-0277-y. Epub 2019 Jun 23.
7
Molecular subtypes of small cell lung cancer: a synthesis of human and mouse model data.小细胞肺癌的分子亚型：人类和小鼠模型数据的综合。
Nat Rev Cancer. 2019 May;19(5):289-297. doi: 10.1038/s41568-019-0133-9.
8
The expression of TTF1, CDX2 and ISL1 in 74 poorly differentiated neuroendocrine carcinomas.74例低分化神经内分泌癌中TTF1、CDX2和ISL1的表达情况
Ann Diagn Pathol. 2018 Dec;37:30-34. doi: 10.1016/j.anndiagpath.2018.09.005. Epub 2018 Sep 13.
9
Intratumoral heterogeneity of Notch1 expression in small cell lung cancer.小细胞肺癌中Notch1表达的肿瘤内异质性。
J Thorac Dis. 2018 Mar;10(3):1272-1275. doi: 10.21037/jtd.2018.03.61.
10
Small cell lung cancer tumors and preclinical models display heterogeneity of neuroendocrine phenotypes.小细胞肺癌肿瘤和临床前模型表现出神经内分泌表型的异质性。
Transl Lung Cancer Res. 2018 Feb;7(1):32-49. doi: 10.21037/tlcr.2018.02.02.